Ardelyx (ARDX) Other Non-Current Liabilities (2013 - 2026)

Ardelyx's (ARDX) quarterly Other Non-Current Liabilities came in at $25.9 million in Q1 2026, down 2.48% YoY from $26.5 million in Q1 2025, and little changed on a QoQ basis from $25.9 million in Q4 2025.

Ardelyx (ARDX) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

Ardelyx (ARDX) has 13 years of Other Non-Current Liabilities data on file, last reported at $25.9 million in Q1 2026.

  • Quarterly Other Non-Current Liabilities fell 2.48% year-over-year to $25.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.9 million (down 2.48% YoY) and the FY2025 annual result came in at $25.9 million, up 1.37% from the prior year.
  • Other Non-Current Liabilities held at $25.9 million in Q1 2026, from $25.9 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $28.6 million in Q3 2025 to a low of $170000.0 in Q3 2023.
  • A 5-year average of $19.2 million and a median of $22.5 million in 2024 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 98.37% — and 2024, when it surged 14236.47%.
  • Tracing ARDX's Other Non-Current Liabilities over 5 years: stood at $11.3 million in 2022, then surged by 79.31% to $20.2 million in 2023, then increased by 26.5% to $25.5 million in 2024, then increased by 1.37% to $25.9 million in 2025, then declined by 0.05% to $25.9 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $25.9 million (Q1 2026), $25.9 million (Q4 2025), and $28.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 26.32 Mn
Mar 31, 2026 25.86 Mn
Dec 31, 2025 25.88 Mn
Sep 30, 2025 28.63 Mn
Jun 30, 2025 27.76 Mn
Mar 31, 2025 26.52 Mn
Dec 31, 2024 25.53 Mn
Sep 30, 2024 24.37 Mn
Jun 30, 2024 23.10 Mn
Mar 31, 2024 21.88 Mn
Dec 31, 2023 20.18 Mn
Sep 30, 2023 170,000.00
Jun 30, 2023 13.19 Mn
Mar 31, 2023 12.22 Mn
Dec 31, 2022 11.25 Mn
Sep 30, 2022 10.42 Mn
Jun 30, 2022 9.59 Mn
Dec 31, 2020 1.38 Mn
Sep 30, 2020 1.26 Mn
Jun 30, 2020 1.12 Mn